FI932744A - Framstaellningsmetod och mellanprodukter foer bis-azabicykliska aongestfoermildrande aemnen - Google Patents

Framstaellningsmetod och mellanprodukter foer bis-azabicykliska aongestfoermildrande aemnen Download PDF

Info

Publication number
FI932744A
FI932744A FI932744A FI932744A FI932744A FI 932744 A FI932744 A FI 932744A FI 932744 A FI932744 A FI 932744A FI 932744 A FI932744 A FI 932744A FI 932744 A FI932744 A FI 932744A
Authority
FI
Finland
Prior art keywords
image
pct
framstaellningsmetod
azabicykliska
aongestfoermildrande
Prior art date
Application number
FI932744A
Other languages
English (en)
Other versions
FI102898B1 (fi
FI932744A0 (fi
FI102898B (fi
Inventor
Frank J Urban
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of FI932744A0 publication Critical patent/FI932744A0/fi
Publication of FI932744A publication Critical patent/FI932744A/fi
Priority to FI982486A priority Critical patent/FI982486A0/fi
Application granted granted Critical
Publication of FI102898B1 publication Critical patent/FI102898B1/fi
Publication of FI102898B publication Critical patent/FI102898B/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Anesthesiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Indole Compounds (AREA)
FI932744A 1992-06-16 1993-06-15 Menetelmä pyrido£1,2-a|pyratsiinivälituotteiden valmistamiseksi FI102898B (fi)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FI982486A FI982486A0 (fi) 1992-06-16 1998-11-17 Välituotteet bis-atsa-bisyklisille ahdistusta lievittäville aineille

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US89956092A 1992-06-16 1992-06-16
US89956092 1992-06-16

Publications (4)

Publication Number Publication Date
FI932744A0 FI932744A0 (fi) 1993-06-15
FI932744A true FI932744A (fi) 1993-12-17
FI102898B1 FI102898B1 (fi) 1999-03-15
FI102898B FI102898B (fi) 1999-03-15

Family

ID=25411215

Family Applications (2)

Application Number Title Priority Date Filing Date
FI932744A FI102898B (fi) 1992-06-16 1993-06-15 Menetelmä pyrido£1,2-a|pyratsiinivälituotteiden valmistamiseksi
FI982486A FI982486A0 (fi) 1992-06-16 1998-11-17 Välituotteet bis-atsa-bisyklisille ahdistusta lievittäville aineille

Family Applications After (1)

Application Number Title Priority Date Filing Date
FI982486A FI982486A0 (fi) 1992-06-16 1998-11-17 Välituotteet bis-atsa-bisyklisille ahdistusta lievittäville aineille

Country Status (11)

Country Link
US (1) US5719286A (fi)
EP (1) EP0646116B1 (fi)
JP (2) JP2753146B2 (fi)
AT (1) ATE185565T1 (fi)
CA (1) CA2138018C (fi)
DE (1) DE69326767T2 (fi)
DK (1) DK0646116T3 (fi)
ES (1) ES2137986T3 (fi)
FI (2) FI102898B (fi)
GR (1) GR3032285T3 (fi)
WO (1) WO1993025552A1 (fi)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5455350A (en) * 1993-10-13 1995-10-03 Pfizer Inc. Process and intermediate for certain bis-aza-bicyclic anxiolytic agents
WO1996010570A1 (en) * 1994-09-30 1996-04-11 Pfizer Inc. NEUROLEPTIC 2,7-DISUBSTITUTED PERHYDRO-1H-PYRIDO[1,2-a]PYRAZINES
WO1996010571A1 (en) * 1994-09-30 1996-04-11 Pfizer Inc. 2,7-SUBSTITUTED OCTAHYDRO-1H-PYRIDO[1,2-a]PYRAZINE DERIVATIVES
PA8469101A1 (es) * 1998-04-09 2000-09-29 Pfizer Prod Inc Ligandos azabiciclicos de receptores 5ht1
JP3910627B2 (ja) * 2003-03-12 2007-04-25 ファイザー・プロダクツ・インク ピリジルオキシメチルおよびベンゾイソオキサゾールのアザビシクロ環の誘導体

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1990008148A1 (en) * 1989-01-23 1990-07-26 Pfizer Inc. Bis-aza-bicyclic anxiolytic agents
US4956368A (en) * 1989-07-24 1990-09-11 Bristol-Myers Company Metabolites and prodrug formulations of 8-[4-[4-(1,2-benzisothiazol-3-yl)-1-piperazinyl]butyl]-8-azaspiro[4.5]decane-7,9-dione
EP0569387B1 (en) * 1991-01-31 1995-04-05 Pfizer Inc. Resolution of trans-2-(2-pyrimidinyl)-7-(hydroxymethyl)octahydro-2h-pyrido 1,2-a]pyrazine
US5157034A (en) * 1991-02-27 1992-10-20 Pfizer Inc. Neuroleptic perhydro-1H-pyrido[1,2-a]pyrazines

Also Published As

Publication number Publication date
FI102898B1 (fi) 1999-03-15
EP0646116B1 (en) 1999-10-13
GR3032285T3 (en) 2000-04-27
DE69326767D1 (de) 1999-11-18
JPH09176166A (ja) 1997-07-08
FI932744A0 (fi) 1993-06-15
FI102898B (fi) 1999-03-15
US5719286A (en) 1998-02-17
JP2744224B2 (ja) 1998-04-28
CA2138018A1 (en) 1993-12-23
ES2137986T3 (es) 2000-01-01
JPH07504678A (ja) 1995-05-25
DK0646116T3 (da) 1999-12-27
FI982486A0 (fi) 1998-11-17
WO1993025552A1 (en) 1993-12-23
JP2753146B2 (ja) 1998-05-18
EP0646116A1 (en) 1995-04-05
ATE185565T1 (de) 1999-10-15
DE69326767T2 (de) 2000-03-02
CA2138018C (en) 1998-01-27

Similar Documents

Publication Publication Date Title
FI932229A0 (fi) Azabicykliska bryggderivat
DK0915866T3 (da) Forbedret fremgangsmåde til syntese af beskyttende estere af (S)-3,4-dihydroxysmørsyre
TW274547B (fi)
IL102208A0 (en) Azanorbornane derivatives
FI940105A (fi) Menetelmä sertraliinivälituotteiden valmistamiseksi
GR3034769T3 (en) Triazole antifungal agents.
DE69426836D1 (de) Antivirale 2,4-pyrimidindion-derivate und verfahren zu ihrer herstellung
ES2138623T3 (es) Derivados de pleuromutilina.
DK0594666T3 (da) Fremgangsmåde til fremstilling af sertralin
FI932744A0 (fi) Framstaellningsmetod och mellanprodukter foer bis-azabicykliska aongestfoermildrande aemnen
GB9405492D0 (en) Chemical compounds
EA200200352A1 (ru) Фенил- и пиридил-тетрагидропиридины, обладающие ингибирующей активностью в отношении фактора некроза опухоли (фно)